Загрузка...
Plasma microbiome in COVID-19 subjects: an indicator of gut barrier defects and dysbiosis
The gut is a well-established route of infection and target for viral damage by SARS-CoV-2. This is supported by the clinical observation that about half of COVID-19 patients exhibit gastrointestinal ( GI ) symptoms. We asked whether the analysis of plasma could provide insight into gut barrier dysf...
Сохранить в:
| Опубликовано в: : | bioRxiv |
|---|---|
| Главные авторы: | , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Cold Spring Harbor Laboratory
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8043449/ https://ncbi.nlm.nih.gov/pubmed/33851159 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2021.04.06.438634 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|